DNA methylation epigenotypes in breast cancer molecular subtypes
2010

DNA Methylation Profiles in Breast Cancer Subtypes

Sample size: 215 publication Evidence: high

Author Information

Author(s): Bediaga Naiara G, Acha-Sagredo Amelia, Guerra Isabel, Viguri Amparo, Albaina Carmen, Ruiz Diaz Irune, Rezola Ricardo, Alberdi María Jesus, Dopazo Joaquín, Montaner David, de Renobales Mertxe, Fernández Agustín F, Field John K, Fraga Mario F, Liloglou Triantafillos, de Pancorbo Marian M

Primary Institution: Centro de Investigacion y Estudios Avanzados 'Lucio Lascaray', University of the Basque Country UPV/EHU

Hypothesis

The study aims to identify specific DNA methylation profiles associated with different breast cancer molecular subtypes.

Conclusion

The study provides evidence that distinct DNA methylation profiles can predict breast cancer subtypes, which may aid in patient prognostication and treatment strategies.

Supporting Evidence

  • The study identified 15 differentially methylated CpG loci associated with breast cancer subtypes.
  • Validation of findings was performed using pyrosequencing in an independent cohort of 187 samples.
  • Distinct methylation profiles were observed in basal-like and HER2-overexpressing tumors.
  • The study supports the use of DNA methylation as a biomarker for breast cancer subtype classification.
  • Methylation changes were linked to clinicopathologic features such as nodal involvement and p53 mutation status.

Takeaway

This study found that different types of breast cancer have unique patterns of DNA changes, which can help doctors understand and treat the disease better.

Methodology

The study analyzed DNA methylation in 806 cancer-related genes using microarray technology and validated findings with pyrosequencing in paired breast cancer samples.

Limitations

The study may have limitations related to the sample size and the specific populations studied, which may not be generalizable.

Participant Demographics

The study included 215 patients diagnosed with ductal infiltrative breast carcinoma, with various subtypes represented.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr2721

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication